ApoGen increases 2016 Series A funding round to $11 million
Company draws $4 million in additional funding from Merck KGaA's venture capital arm and other investors.
WuXi launches $250M fund to invest in life sciences startups
WuXi PharmaTech, a Chinese R&D powerhouse, is launching its second fund. It wants to invest $250 million into healthcare and life sciences startups in the U.S. and China.
Why Pharma Companies Should Look To Social Media For Better Patient Insight
Healthcare decision-makers, especially at pharmaceutical companies, must prioritize patient input. Data collected from social media listening is a significant step in the right direction.